UCI Urology Team Developing Unique Endoscope to Improve Kidney Stone Surgery

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

UCI Urology (four Urologists), who specialize in kidney stone diseases include Dr. Pengbo Jiang, Dr. Jaime Landman, Dr. Roshan Patel, and Dr. Ralph V. Clayman, have teamed up with UCI CALIT2 engineers, Dr. William Mao, Dr. Mike Klopfer, and G. P. Li to design a new ureteroscope that is capable of removing all kidney stone fragments during surgery.

The team has six months to complete the project and has received a grant to develop the technology.

UCI Urology, Team Developing Unique Endoscope to Improve Kidney Stone Surgery
UCI Urology Team Developing Unique Endoscope to Improve Kidney Stone Surgery

Approximately 10% of the U.S. population will experience a kidney stone. The primary treatment goals are to remove the stone with the least amount of patient discomfort and to prevent recurrence. One of the least invasive options for surgery involves using a non-incisional approach by entering the urinary tract with a ureteroscope. This type of endoscopic approach allows the urologist to access a stone and use a laser to break the stone into fragments.

Unfortunately, with the current technology, many of the smallest fragments cannot be recovered and removed. In fact, with the ureteroscope, even the best stone clearance rates are no better than 50 to 60%. The remaining fragments (about 2mm or smaller in size) can contribute to the formation of recurring stones within two years in as many as 40% of patients.

The UCI team seeks to develop instrumentation that is able to leave the kidney fragment-free following stone removal. The team’s proposal has been awarded a UCI Beall Applied Innovation Proof of Product (POP) grant, a funding program that accelerates commercially promising technology.

Dr. Ralph Clayman stated, “The POP grant has empowered and energized our work in this area. I am optimistic that given the great partnership we have with CALIT2 and the School of Engineering, within six months we will have a working prototype. This work has the potential to vastly improve surgical outcomes for all patients with kidney stones.”

The team has six months to complete this project and will utilize the Surgical Education and Research Center located at UCI Medical Center, Orange, CA. If successful, a disposable ureteroscope will be created that is able to remove all stone fragments, regardless of size. The ureteroscope will have additional features designed to improve the efficiency and effectiveness of stone removal, such as multiple laser channels and multidirectional deflection.

UCI Urology is at the forefront of research, providing patients with the best in innovative and less invasive urologic care. The department has a core mission to discover new advances in healthcare, teach tomorrow’s medical professionals, and heal patients with individualized care.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.